Stocks
Abivax Stock Surge: Next Big Biotech Takeover Target
Abivax's stock exploded nearly 1700% in 2025 thanks to breakthrough ulcerative colitis data. Now analysts say a massive takeover—potentially worth...
09/01/2026
2 views